Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allogeneic Stem Cell Transplantation Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Unmodified Stem Cell Transplant
1.2.3 T-cell Depleted Transplant
1.2.4 Cord Blood Transplant
1.2.5 Donor Lymphocyte Infusion
1.3 Market by Application
1.3.1 Global Allogeneic Stem Cell Transplantation Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allogeneic Stem Cell Transplantation Market Perspective (2018-2033)
2.2 Allogeneic Stem Cell Transplantation Growth Trends by Region
2.2.1 Global Allogeneic Stem Cell Transplantation Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Allogeneic Stem Cell Transplantation Historic Market Size by Region (2018-2023)
2.2.3 Allogeneic Stem Cell Transplantation Forecasted Market Size by Region (2024-2033)
2.3 Allogeneic Stem Cell Transplantation Market Dynamics
2.3.1 Allogeneic Stem Cell Transplantation Industry Trends
2.3.2 Allogeneic Stem Cell Transplantation Market Drivers
2.3.3 Allogeneic Stem Cell Transplantation Market Challenges
2.3.4 Allogeneic Stem Cell Transplantation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allogeneic Stem Cell Transplantation Players by Revenue
3.1.1 Global Top Allogeneic Stem Cell Transplantation Players by Revenue (2018-2023)
3.1.2 Global Allogeneic Stem Cell Transplantation Revenue Market Share by Players (2018-2023)
3.2 Global Allogeneic Stem Cell Transplantation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Allogeneic Stem Cell Transplantation Revenue
3.4 Global Allogeneic Stem Cell Transplantation Market Concentration Ratio
3.4.1 Global Allogeneic Stem Cell Transplantation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allogeneic Stem Cell Transplantation Revenue in 2022
3.5 Allogeneic Stem Cell Transplantation Key Players Head office and Area Served
3.6 Key Players Allogeneic Stem Cell Transplantation Product Solution and Service
3.7 Date of Enter into Allogeneic Stem Cell Transplantation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Allogeneic Stem Cell Transplantation Breakdown Data by Type
4.1 Global Allogeneic Stem Cell Transplantation Historic Market Size by Type (2018-2023)
4.2 Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Type (2024-2033)
5 Allogeneic Stem Cell Transplantation Breakdown Data by Application
5.1 Global Allogeneic Stem Cell Transplantation Historic Market Size by Application (2018-2023)
5.2 Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Allogeneic Stem Cell Transplantation Market Size (2018-2033)
6.2 North America Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Allogeneic Stem Cell Transplantation Market Size by Country (2018-2023)
6.4 North America Allogeneic Stem Cell Transplantation Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allogeneic Stem Cell Transplantation Market Size (2018-2033)
7.2 Europe Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Allogeneic Stem Cell Transplantation Market Size by Country (2018-2023)
7.4 Europe Allogeneic Stem Cell Transplantation Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allogeneic Stem Cell Transplantation Market Size (2018-2033)
8.2 Asia-Pacific Allogeneic Stem Cell Transplantation Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2018-2023)
8.4 Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allogeneic Stem Cell Transplantation Market Size (2018-2033)
9.2 Latin America Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2018-2023)
9.4 Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size (2018-2033)
10.2 Middle East & Africa Allogeneic Stem Cell Transplantation Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2018-2023)
10.4 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mesoblast Limited
11.1.1 Mesoblast Limited Company Detail
11.1.2 Mesoblast Limited Business Overview
11.1.3 Mesoblast Limited Allogeneic Stem Cell Transplantation Introduction
11.1.4 Mesoblast Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.1.5 Mesoblast Limited Recent Development
11.2 Gamida Cell Ltd.
11.2.1 Gamida Cell Ltd. Company Detail
11.2.2 Gamida Cell Ltd. Business Overview
11.2.3 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Introduction
11.2.4 Gamida Cell Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.2.5 Gamida Cell Ltd. Recent Development
11.3 Novartis International AG
11.3.1 Novartis International AG Company Detail
11.3.2 Novartis International AG Business Overview
11.3.3 Novartis International AG Allogeneic Stem Cell Transplantation Introduction
11.3.4 Novartis International AG Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.3.5 Novartis International AG Recent Development
11.4 Cellectis SA
11.4.1 Cellectis SA Company Detail
11.4.2 Cellectis SA Business Overview
11.4.3 Cellectis SA Allogeneic Stem Cell Transplantation Introduction
11.4.4 Cellectis SA Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.4.5 Cellectis SA Recent Development
11.5 Magenta Therapeutics Inc.
11.5.1 Magenta Therapeutics Inc. Company Detail
11.5.2 Magenta Therapeutics Inc. Business Overview
11.5.3 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.5.4 Magenta Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.5.5 Magenta Therapeutics Inc. Recent Development
11.6 Fate Therapeutics Inc.
11.6.1 Fate Therapeutics Inc. Company Detail
11.6.2 Fate Therapeutics Inc. Business Overview
11.6.3 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.6.4 Fate Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.6.5 Fate Therapeutics Inc. Recent Development
11.7 Cynata Therapeutics Limited
11.7.1 Cynata Therapeutics Limited Company Detail
11.7.2 Cynata Therapeutics Limited Business Overview
11.7.3 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Introduction
11.7.4 Cynata Therapeutics Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.7.5 Cynata Therapeutics Limited Recent Development
11.8 Kiadis Pharma N.V
11.8.1 Kiadis Pharma N.V Company Detail
11.8.2 Kiadis Pharma N.V Business Overview
11.8.3 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Introduction
11.8.4 Kiadis Pharma N.V Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.8.5 Kiadis Pharma N.V Recent Development
11.9 Takeda Pharmaceutical Company Limited
11.9.1 Takeda Pharmaceutical Company Limited Company Detail
11.9.2 Takeda Pharmaceutical Company Limited Business Overview
11.9.3 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Introduction
11.9.4 Takeda Pharmaceutical Company Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.9.5 Takeda Pharmaceutical Company Limited Recent Development
11.10 JCR Pharmaceuticals Co., Ltd.
11.10.1 JCR Pharmaceuticals Co., Ltd. Company Detail
11.10.2 JCR Pharmaceuticals Co., Ltd. Business Overview
11.10.3 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Introduction
11.10.4 JCR Pharmaceuticals Co., Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.10.5 JCR Pharmaceuticals Co., Ltd. Recent Development
11.11 Pluristem Therapeutics Inc.
11.11.1 Pluristem Therapeutics Inc. Company Detail
11.11.2 Pluristem Therapeutics Inc. Business Overview
11.11.3 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.11.4 Pluristem Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.11.5 Pluristem Therapeutics Inc. Recent Development
11.12 Celularity Inc.
11.12.1 Celularity Inc. Company Detail
11.12.2 Celularity Inc. Business Overview
11.12.3 Celularity Inc. Allogeneic Stem Cell Transplantation Introduction
11.12.4 Celularity Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.12.5 Celularity Inc. Recent Development
11.13 Lineage Cell Therapeutics Inc.
11.13.1 Lineage Cell Therapeutics Inc. Company Detail
11.13.2 Lineage Cell Therapeutics Inc. Business Overview
11.13.3 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.13.4 Lineage Cell Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.13.5 Lineage Cell Therapeutics Inc. Recent Development
11.14 Nohla Therapeutics Inc.
11.14.1 Nohla Therapeutics Inc. Company Detail
11.14.2 Nohla Therapeutics Inc. Business Overview
11.14.3 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Introduction
11.14.4 Nohla Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.14.5 Nohla Therapeutics Inc. Recent Development
11.15 Orchard Therapeutics Plc
11.15.1 Orchard Therapeutics Plc Company Detail
11.15.2 Orchard Therapeutics Plc Business Overview
11.15.3 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Introduction
11.15.4 Orchard Therapeutics Plc Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023)
11.15.5 Orchard Therapeutics Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Allogeneic Stem Cell Transplantation Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Unmodified Stem Cell Transplant
Table 3. Key Players of T-cell Depleted Transplant
Table 4. Key Players of Cord Blood Transplant
Table 5. Key Players of Donor Lymphocyte Infusion
Table 6. Global Allogeneic Stem Cell Transplantation Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Allogeneic Stem Cell Transplantation Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Allogeneic Stem Cell Transplantation Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Allogeneic Stem Cell Transplantation Market Share by Region (2018-2023)
Table 10. Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Allogeneic Stem Cell Transplantation Market Share by Region (2024-2033)
Table 12. Allogeneic Stem Cell Transplantation Market Trends
Table 13. Allogeneic Stem Cell Transplantation Market Drivers
Table 14. Allogeneic Stem Cell Transplantation Market Challenges
Table 15. Allogeneic Stem Cell Transplantation Market Restraints
Table 16. Global Allogeneic Stem Cell Transplantation Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Allogeneic Stem Cell Transplantation Market Share by Players (2018-2023)
Table 18. Global Top Allogeneic Stem Cell Transplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Transplantation as of 2022)
Table 19. Ranking of Global Top Allogeneic Stem Cell Transplantation Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Allogeneic Stem Cell Transplantation Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Allogeneic Stem Cell Transplantation Product Solution and Service
Table 23. Date of Enter into Allogeneic Stem Cell Transplantation Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Allogeneic Stem Cell Transplantation Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Type (2018-2023)
Table 27. Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Type (2024-2033)
Table 29. Global Allogeneic Stem Cell Transplantation Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Application (2018-2023)
Table 31. Global Allogeneic Stem Cell Transplantation Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Application (2024-2033)
Table 33. North America Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Allogeneic Stem Cell Transplantation Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Allogeneic Stem Cell Transplantation Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Allogeneic Stem Cell Transplantation Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Allogeneic Stem Cell Transplantation Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Allogeneic Stem Cell Transplantation Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Country (2024-2033) & (US$ Million)
Table 48. Mesoblast Limited Company Detail
Table 49. Mesoblast Limited Business Overview
Table 50. Mesoblast Limited Allogeneic Stem Cell Transplantation Product
Table 51. Mesoblast Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 52. Mesoblast Limited Recent Development
Table 53. Gamida Cell Ltd. Company Detail
Table 54. Gamida Cell Ltd. Business Overview
Table 55. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product
Table 56. Gamida Cell Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 57. Gamida Cell Ltd. Recent Development
Table 58. Novartis International AG Company Detail
Table 59. Novartis International AG Business Overview
Table 60. Novartis International AG Allogeneic Stem Cell Transplantation Product
Table 61. Novartis International AG Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 62. Novartis International AG Recent Development
Table 63. Cellectis SA Company Detail
Table 64. Cellectis SA Business Overview
Table 65. Cellectis SA Allogeneic Stem Cell Transplantation Product
Table 66. Cellectis SA Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 67. Cellectis SA Recent Development
Table 68. Magenta Therapeutics Inc. Company Detail
Table 69. Magenta Therapeutics Inc. Business Overview
Table 70. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 71. Magenta Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 72. Magenta Therapeutics Inc. Recent Development
Table 73. Fate Therapeutics Inc. Company Detail
Table 74. Fate Therapeutics Inc. Business Overview
Table 75. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 76. Fate Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 77. Fate Therapeutics Inc. Recent Development
Table 78. Cynata Therapeutics Limited Company Detail
Table 79. Cynata Therapeutics Limited Business Overview
Table 80. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product
Table 81. Cynata Therapeutics Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 82. Cynata Therapeutics Limited Recent Development
Table 83. Kiadis Pharma N.V Company Detail
Table 84. Kiadis Pharma N.V Business Overview
Table 85. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product
Table 86. Kiadis Pharma N.V Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 87. Kiadis Pharma N.V Recent Development
Table 88. Takeda Pharmaceutical Company Limited Company Detail
Table 89. Takeda Pharmaceutical Company Limited Business Overview
Table 90. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product
Table 91. Takeda Pharmaceutical Company Limited Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 92. Takeda Pharmaceutical Company Limited Recent Development
Table 93. JCR Pharmaceuticals Co., Ltd. Company Detail
Table 94. JCR Pharmaceuticals Co., Ltd. Business Overview
Table 95. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product
Table 96. JCR Pharmaceuticals Co., Ltd. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 97. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 98. Pluristem Therapeutics Inc. Company Detail
Table 99. Pluristem Therapeutics Inc. Business Overview
Table 100. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 101. Pluristem Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 102. Pluristem Therapeutics Inc. Recent Development
Table 103. Celularity Inc. Company Detail
Table 104. Celularity Inc. Business Overview
Table 105. Celularity Inc. Allogeneic Stem Cell Transplantation Product
Table 106. Celularity Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 107. Celularity Inc. Recent Development
Table 108. Lineage Cell Therapeutics Inc. Company Detail
Table 109. Lineage Cell Therapeutics Inc. Business Overview
Table 110. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 111. Lineage Cell Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 112. Lineage Cell Therapeutics Inc. Recent Development
Table 113. Nohla Therapeutics Inc. Company Detail
Table 114. Nohla Therapeutics Inc. Business Overview
Table 115. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product
Table 116. Nohla Therapeutics Inc. Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 117. Nohla Therapeutics Inc. Recent Development
Table 118. Orchard Therapeutics Plc Company Detail
Table 119. Orchard Therapeutics Plc Business Overview
Table 120. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product
Table 121. Orchard Therapeutics Plc Revenue in Allogeneic Stem Cell Transplantation Business (2018-2023) & (US$ Million)
Table 122. Orchard Therapeutics Plc Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Allogeneic Stem Cell Transplantation Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Allogeneic Stem Cell Transplantation Market Share by Type: 2022 VS 2033
Figure 3. Unmodified Stem Cell Transplant Features
Figure 4. T-cell Depleted Transplant Features
Figure 5. Cord Blood Transplant Features
Figure 6. Donor Lymphocyte Infusion Features
Figure 7. Global Allogeneic Stem Cell Transplantation Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Allogeneic Stem Cell Transplantation Market Share by Application: 2022 VS 2033
Figure 9. Hospital Case Studies
Figure 10. Ambulatory Surgical Center Case Studies
Figure 11. Others Case Studies
Figure 12. Allogeneic Stem Cell Transplantation Report Years Considered
Figure 13. Global Allogeneic Stem Cell Transplantation Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Allogeneic Stem Cell Transplantation Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Allogeneic Stem Cell Transplantation Market Share by Region: 2022 VS 2033
Figure 16. Global Allogeneic Stem Cell Transplantation Market Share by Players in 2022
Figure 17. Global Top Allogeneic Stem Cell Transplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Transplantation as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Allogeneic Stem Cell Transplantation Revenue in 2022
Figure 19. North America Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Allogeneic Stem Cell Transplantation Market Share by Country (2018-2033)
Figure 21. United States Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Allogeneic Stem Cell Transplantation Market Share by Country (2018-2033)
Figure 25. Germany Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Allogeneic Stem Cell Transplantation Market Share by Region (2018-2033)
Figure 33. China Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Allogeneic Stem Cell Transplantation Market Share by Country (2018-2033)
Figure 41. Mexico Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Allogeneic Stem Cell Transplantation Market Share by Country (2018-2033)
Figure 45. Turkey Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Allogeneic Stem Cell Transplantation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Mesoblast Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 48. Gamida Cell Ltd. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 49. Novartis International AG Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 50. Cellectis SA Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 51. Magenta Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 52. Fate Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 53. Cynata Therapeutics Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 54. Kiadis Pharma N.V Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 55. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 56. JCR Pharmaceuticals Co., Ltd. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 57. Pluristem Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 58. Celularity Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 59. Lineage Cell Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 60. Nohla Therapeutics Inc. Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 61. Orchard Therapeutics Plc Revenue Growth Rate in Allogeneic Stem Cell Transplantation Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed